← Back to Search

mHealth App for Kidney Transplant Care

N/A

Recruiting

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥18 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial tests a smartphone app to help kidney transplant patients track meds, BP, & glucose, with the goal of improving care & outcomes, especially for African Americans.

Who is the study for?

This trial is for kidney transplant patients who are at least 18 years old and two or more years post-transplant. It's focused on helping African American patients in particular. Participants must be able to measure their own blood pressure and glucose if diabetic, use a mobile health app after training, and speak, hear, and read English.Check my eligibility

What is being tested?

The study is testing a smartphone app managed by pharmacists that helps track medications, blood pressures, and blood sugars for those with diabetes. The aim is to see if this mHealth tool can improve medication adherence and overall outcomes after kidney transplants.See study design

What are the potential side effects?

Since the intervention involves using an mHealth app rather than a drug or medical procedure, there aren't typical side effects like you'd expect from medications. However, users may experience issues related to technology use such as frustration or difficulty with the interface.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acute Rejection

Blood Pressure

Cost-Benefit Analysis

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention GroupExperimental Treatment1 Intervention

Usual Care + mHealth/Telehealth

Group II: Control GroupActive Control1 Intervention

Usual Care + Attention Control

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor

933 Previous Clinical Trials

7,394,446 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,359 Previous Clinical Trials

4,314,402 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are enrollees being accepted into this trial currently?

"Information available on clinicaltrials.gov verifies that this medical study, which was created on November 1st 2023, is not currently recruiting participants. However, there are 88 other trials looking for volunteers at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MITIGAAT: Multifaceted Intervention To Improve Graft Outcome Disparities in African American Kidney Transplants

David J. Taber 2024. "MITIGAAT: Multifaceted Intervention To Improve Graft Outcome Disparities in African American Kidney Transplants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06023615.

All > Kidney Transplant